<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04183231</url>
  </required_header>
  <id_info>
    <org_study_id>2016-04-05</org_study_id>
    <nct_id>NCT04183231</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Advantage Anti-Caries Varnish</brief_title>
  <official_title>Pharmacokinetics of Advantage Anti-Caries Varnish</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advantage Silver Dental Arrest, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Advantage Silver Dental Arrest, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aim is to characterize the kinetics of iodine and fluoride following topical
      application of a combined PVP-I and NaF anti-dental caries varnish in healthy adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was to characterize serum iodine and fluoride levels over 24 hours after
      application of a topical dental varnish in healthy adults 23 to 57 years old.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2016</start_date>
  <completion_date type="Actual">April 25, 2018</completion_date>
  <primary_completion_date type="Actual">February 28, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open label exposure--response study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Observed Iodine Tmax</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Time to maximum serum concentration of iodine in hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Iodine Cmax</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Maximum serum concentration of iodine in ng/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Iodine AUC</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Area under the Curve for observed iodine in ng-h/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Iodine Total Urinary Recovery</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Total urinary recovery in milligrams</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Iodine Baseline-Corrected Cmax</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Maximum serum concentration of iodine in ng/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Iodine Baseline-Corrected AUC</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Area under the Curve for observed iodine in ng-h/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Iodine Baseline-Corrected T1/2</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Terminal elimination half-life in hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Fluoride Tmax</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Time to maximum serum concentration in hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Fluoride Cmax</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Maximum serum concentration of fluoride in ng/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Fluoride AUC</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Area under the Curve for observed fluoride in ng-h/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Fluoride Baseline-Corrected Cmax</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Maximum serum concentration of iodine in ng/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Fluoride Baseline-Corrected AUC</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Area under the Curve for observed fluoride in ng-h/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Fluoride Baseline-Corrected T1/2</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Terminal elimination half-life in hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed serum iodine concentrations</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Kinetics of iodine serum concentration versus time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed serum iodine concentrations baseline-corrected</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Kinetics of iodine serum concentration versus time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed serum fluoride concentrations baseline-corrected</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Kinetics of fluoride serum concentration versus time</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Dental Caries</condition>
  <arm_group>
    <arm_group_label>Anti-caries varnish</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>topical dental varnish, 10% PVP-I, 2.5% NaF, topical application to teeth, 0.4 ml, single application</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anti-caries varnish</intervention_name>
    <description>topical tooth varnish</description>
    <arm_group_label>Anti-caries varnish</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults 18 y and older, at least 20 teeth, not taking prescription or OTC
             medications.

        Exclusion Criteria:

          -  Pregnant, weighed less than 110 pounds, had oral mucositis, ulcerative lesions,
             sensitivity to shellfish or iodine or fluoride varnish, or had known hypothyroidism,
             hyperthyroidism, dermatitis herpetiformis, hypocomplementemic vasculitis, nodular
             thread with heart disease, multi nodular goiter, Graves disease, or autoimmune
             thyroiditis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yvonne Lin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington School of Pharmacy</affiliation>
  </overall_official>
  <results_reference>
    <citation>Lin YS, Rothen ML, Milgrom P. Pharmacokinetics of Iodine and Fluoride following Application of an Anticaries Varnish in Adults. JDR Clin Trans Res. 2018 Jul;3(3):238-245. doi: 10.1177/2380084418771930. Epub 2018 Apr 25.</citation>
    <PMID>30938600</PMID>
  </results_reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 27, 2019</study_first_submitted>
  <study_first_submitted_qc>November 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>November 30, 2019</last_update_submitted>
  <last_update_submitted_qc>November 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adults</keyword>
  <keyword>povidone iodine</keyword>
  <keyword>sodium fluoride</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Caries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>July 10, 2020</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

